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ABSTRACT Superantigens (SAgs) represent a diverse family of bacterial toxins that
induce V-specific T cell proliferation associated with an array of important diseases
in humans and animals, including mastitis of dairy cows. However, an understanding
of the diversity and distribution of SAg genes among bovine Staphylococcus aureus
strains and their role in the pathogenesis of mastitis is lacking. Population genomic
analysis of 195 bovine S. aureus isolates representing 57 unique sequence types re-
vealed that strains encode 2 to 13 distinct SAgs and that the majority of isolates
contain 5 or more SAg genes. A genome-scale analysis of bovine reference strain
RF122 revealed a complement of 11 predicted SAg genes, which were all expressed
in vitro. Detection of specific antibodies in convalescent cows suggests expression of
7 of 11 SAgs during natural S. aureus infection. We determined the V T cell activa-
tion profile for all functional SAgs encoded by RF122, revealing evidence for bovine
host-specific activity among the recently identified RF122-encoded SAgs SElY and
SElZ. Remarkably, we discovered that some strains have evolved the capacity to
stimulate the entire T cell repertoire of cattle through an array of diverse SAgs, sug-
gesting a key role in bovine immune evasion.
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Staphylococcus aureus produces a family of at least 26 distinct superantigens (SAgs),including the staphylococcal enterotoxins (SEs) SEA to -E, SEG to -J, and SER to -T;
the staphylococcal enterotoxin-like toxins (SEls) SElK to -Q, -U, -V, and -X to -Z; and toxic
shock syndrome toxin 1 (TSST-1) (1, 2). SAgs induce the V-specific proliferation of T
cells along with the release of proinflammatory cytokines, including interleukin-1 (IL-1),
IL-2, IL-6, tumor necrosis factor alpha (TNF-), and gamma interferon (IFN-), and the
chemokines CCL2 and CCL3 (3, 4). The uncontrolled release of proinflammatory medi-
ators can lead to rashes, fever, multiorgan damage, coma, and death from severe shock
(1). The release of proinflammatory signals can impede the effectiveness of the immune
response by creating a bias toward either the Th1 or Th17 response, disrupting the
appropriate recruitment of effector cells (2). SAgs have been implicated in a wide range
of human diseases, including staphylococcal food poisoning, endocarditis, necrotizing
pneumonia, and severe toxic shock (1, 5–7). Taken together, the effects induced by
SAgs are likely to cause a significant deficiency in the ability of the adaptive immune
response to contribute effectively to clearance during S. aureus infection.
S. aureus is a common cause of bovine mastitis, an infection of the milk-secreting
tissue of the udder, which represents a huge economic problem for the dairy industry
worldwide (48, 49), establishing a typically chronic infection (8). The exact role of SAgs
in this disease is currently unknown; however, it has been proposed that superantigenic
activity may contribute to the persistence observed (9, 10). Although V-specific
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activation of human T cells in response to staphylococcal SAgs has been well charac-
terized (11–14), relatively little is known about V-specific proliferation of bovine T cells.
Previously, SEC and TSST-1 have been shown to induce V-specific proliferation of
bovine T cells (15–17). However, those studies were limited by the number of T cell
receptor beta variable (TRBV) gene sequences available, with only 5 subfamilies, V1, -2,
-4, -13, and -28, included.
The bovine genome sequencing project and cDNA analyses led to the identification
of the full complement of bovine V subfamilies and almost the entire repertoire of
bovine TRBV genes (18, 19). This facilitated the development of a quantitative real-time
PCR (qRT-PCR) assay to study the bovine V (bovV) response to stimulation with the
core genome-encoded SAg SElX (14). S. aureus strain RF122 belongs to the common
bovine-specific lineage sequence type 151 (ST151) and was the first animal-associated
isolate to be fully sequenced (20). In this study, we have carried out a comprehensive,
genome-wide analysis of the complement of SAgs encoded by this strain and deter-
mined the capacity of each toxin to activate bovV-specific T cells. We report host-
specific functional activity for several SAgs and reveal the remarkable capacity of
bovine S. aureus for activation of the full bovine T cell repertoire, suggesting a critical
role in immune evasion. Importantly, we have also demonstrated that SAgs produced
by S. aureus may play a role in the development of intramammary infection of dairy
cows.
RESULTS AND DISCUSSION
Population genomic analysis indicates that bovine S. aureus strains contain 2
to 13 SAg genes. We examined 195 bovine S. aureus genome sequences representing
57 unique sequence types (STs) for the presence of all 26 known members of the S.
aureus SAg family (Fig. 1; see also Table S1 in the supplemental material). We employed
a threshold of 90% sequence identity across the entire coding DNA sequence (CDS) to
exclude cross-matches to other members of the same SAg group (Fig. 2; see also Table
S1 in the supplemental material).
Consistent with data from previous studies, selw and selx were found in 100%
(195/195) and 79% (150/195) of isolates analyzed, respectively. Previous studies iden-
tified selw to be inactivated in a large number of human S. aureus isolates examined,
due to the lack of an ATG start codon (21, 22). However, the presence of alternative start
codons (TTG) and a continuous full-length open reading frame and the high level of
sequence conservation across bovine isolates (more than 94% nucleotide sequence
identity) suggest that a high proportion of isolates have a functional selw gene. The selx
FIG 1 RF122 encodes SAgs from all four phylogenetic groups. (a) Maximum likelihood phylogenetic tree of 26 superantigen protein sequences showing
clustering of SAgs into 4 general groups (1). Branches with more than 80% bootstrap support are marked with black or gray circles. SAgs present in the RF122
strain are indicated by asterisks. (b) Circular representation of the genome of reference strain RF122 showing the locations of SAg genes.
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gene was absent only in clonal complex 30 (CC30), consistent with data from previous
reports (14). The egc cluster was present in 21 of the 57 unique STs analyzed and was
highly prevalent within CC30, -151, and -45. The composition of egc varied, with six
different gene arrangements characterized, but a gene complement of seg, sei, selm,
seln, selo, and selu-selu2 was the most common one observed. The bovine staphylo-
coccal pathogenicity island (SaPIbov) was less prevalent than the egc cluster, found in
10 of the 57 STs analyzed, primarily in association with CC133 and CC151. The
plasmid-borne SAg genes sed, sej, and ser were identified together in 4 strains,
FIG 2 Bovine isolates of S. aureus typically contain 5 or more SAg genes. Distribution analysis of SAgs in bovine S. aureus isolates shows the repertoire of SAgs
that are encoded. Phylogeny is based on a core genome alignment, and major clonal complexes are noted. Colored boxes indicate the presence of the SAg
gene and are sorted according to association with mobile genetic elements.
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consistent with the presence of a pIB485-like plasmid as described previously in human
strains (23). The sely and selz genes are distributed in a lineage-specific manner (CC151
and CC9 for sely and CC151 for selz), and the SAg genes sea, seb, seh, selk, selp, and selq
were randomly distributed across the diversity of STs examined, consistent with
horizontal gene transfer. The set and ses genes were not found in any S. aureus
genomes examined, suggesting that they are not important in bovine pathogenesis.
All S. aureus strains examined contained at least 2 and up to 13 SAg genes. The
majority of bovine STs analyzed (31/57) encode 5 or more SAgs, with CC151 isolates,
such as RF122, generally encoding more SAgs (up to 13) than other bovine S. aureus
strains. Fewer than half of the STs (n  26) contained selw and selx only. An important
example is the bovine reference strain Newbould 305, which has been the focus of a
number of studies (24, 25), which encodes a functional copy of selx and a pseudogene
of selw (25). The extensive variation in the SAg gene complements between Newbould
305 and RF122 may have a key impact on the relative pathogenesis of infections caused
by these strains. Newbould 305 is associated with mild and generally subclinical
infection, as opposed to RF122 and other CC151 isolates, which are associated with a
more severe and clinical presentation of the disease (25, 26).
Analysis of the genome of bovine S. aureus isolate RF122 (GenBank accession
number AJ938182) revealed a complement of 11 SAg genes and 2 SAg pseudogenes
(Table 1, Fig. 1, and Table S1). Namely, RF122 contains the previously characterized
SaPIbov that contains tstbov, sellbov, secbov, and the enterotoxin gene cluster (egc) in the
genomic island vSa containing allelic variants of the SAg genes seg, sei, selo, seln, and
selu and a pseudogene of selm. Spread out across other parts of the genome, RF122
also contains selw (pseudogene, SAB_1473c), selx, sely, and selz (Fig. 1). The SAg family
was previously subdivided into phylogenetic groups I to V (group IV is composed
entirely of streptococcal SAgs) (27, 28), and RF122 contains at least 2 genes from each
of the 4 staphylococcal SAg subgroups (Fig. 1). Accordingly, RF122 was selected for
genome-scale analysis of the expression and function of bovine S. aureus SAgs.
Bovine SAg genes are expressed at different levels in a growth-phase-
dependent manner in vitro. Relative transcriptional levels of RF122 SAg genes in the
exponential and stationary phases of growth were determined by qRT-PCR. Transcrip-
tion was detected for all 11 genes and 2 pseudogenes in both growth phases, with
secbov exhibiting the highest level of transcription and selu exhibiting the lowest (Fig.
3). Overall, SAg genes located on SaPIbov were transcribed at higher levels than the selx,
sely, selz, and egc genes and the SAg pseudogenes. The data indicate that SaPIbov SAg
genes and selx are upregulated in stationary phase, consistent with regulatory control
by agr, whereas sely and selz are transcribed maximally in mid-exponential phase,
suggesting agr-independent control. Of note, ST151 strains were previously demon-
strated to have high levels of RNAIII transcription in comparison with other ruminant
TABLE 1 SAgs encoded by S. aureus strain RF122
Gene Toxin (abbreviation) Size (kDa)a Locus tag
Homology with characterized SAg gene
(%) (characterized SAg gene)
tstbov Toxic shock syndrome toxin 1 (TSST-1bov) 22 SAB_RS01910 98 (tst)
secbov Staphylococcal enterotoxin C-bovine (SECbov) 27.6 SAB_RS01930 99 (sec1)
sellbov Staphylococcal enterotoxin-like toxin L-bovine (SElLbov) 24.7 SAB_RS01935 99 (sel1)
segbov Staphylococcal enterotoxin G-bovine (SEGbov) 20.6 SAB1696c 77 (seg1)
seibov Staphylococcal enterotoxin I-bovine (SEIbov) 24.9 SAB_RS09045 97 (sei1)
selnbov Staphylococcal enterotoxin-like toxin N-bovine (SElNbov) 26.1 SAB_RS09035 95 (sen1)
selubov Staphylococcal enterotoxin-like toxin U-bovine (SElUbov) 27.2 SAB_RS09040 97 (selu1)
selmbov Staphylococcal enterotoxin-like toxin M-bovine (SElMbov) NA SAB1700c 87 (selm1)
selobov Staphylococcal enterotoxin-like toxin O-bovine (SElObov) 27.1 SAB_RS09055 98 (selo2)
selw Staphylococcal enterotoxin-like toxin W (SE26) NA SAB1473c 54 (sea1)
selxbov Staphylococcal enterotoxin-like toxin X-bovine (SElXbov) 19.5 SAB_RS01710 45 (tst)
selybov Staphylococcal enterotoxin-like toxin Y-bovine (SElY) 22.5 SAB_RS13070 58 (set)
selzbov Staphylococcal enterotoxin-like toxin Z-bovine (SElZ) 27.1 SAB_RS00140 57 (seg1)
aPredicted size of the mature protein based on the amino acid sequence. Pseudogenes are not included. NA, not applicable.
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clones, which could provide an explanation for the high expression levels of some of
these SAgs (26). In the present study, egc genes were transcribed at low levels,
independent of the growth phase. This finding is consistent with those of Derzelle
et al., who reported low egc transcript levels among 28 human strains (29). However, we
cannot rule out the possibility that the egc genes are expressed at higher levels in vivo,
as has been observed for the streptococcal SAgs SPEA and SPEC (30, 31). The differ-
ential regulation of SAg transcription in vitro suggests that SAgs are expressed at
different stages of infection in vivo.
S. aureus SAgs are expressed during bovine infection. To determine if RF122-
encoded SAgs are expressed during bovine infection, we produced recombinant
proteins for each of the encoded SAgs and carried out Western immunoblot analysis
with convalescent-phase sera from cows (Table 2). A serum sample obtained from a
cow without a history of S. aureus mastitis did not contain antibody reactive to any of
the SAgs tested and was used as a negative control (Table 2). IgG antibodies specific for
8 of the 11 SAgs were detected in at least 1 of the 4 bovine serum samples tested,
whereas recombinant SEIbov (rSEIbov), rSEGbov, and rSElObov were not reactive with any
of the samples tested (Table 2). In a previous study by Wilson et al., rSElXbov was
demonstrated to be reactive with all bovine serum samples tested (14). Most human
adults have antibodies specific for an array of S. aureus SAgs, including SEA, SEB, SEC,
FIG 3 RF122 SAgs are expressed in vitro and exhibit growth-phase-dependent expression. Shown are
transcription levels of RF122-borne SAg genes from exponential- and stationary-phase cultures, relative
to 16S rRNA. Relative quantities of RF122 reverse-transcribed mRNA normalized to the internal control,
16S rRNA, were determined by qRT-PCR. Results shown are the means of data from triplicate experi-
ments, and error bars indicate standard deviations (SD).
TABLE 2 Immunogenicity of recombinant SAg proteins from RF122 with sera from cows
and humans with S. aureus infections
Serum sampleb
Reactivitya
SElZ SElY SEG SEI SElO SElU SElN SEC SElL TSST-1 SElXc
Human
IE19           
IE37           
IE41           
IE51           
IE54           
Bovine
2480           
2487           
2521           
4227           
2211           
a or  indicates whether or not the serum sample is reactive with the SAg protein, respectively.
bHuman serum samples were obtained from infective endocarditis patients between 2006 and 2009 at the
New Royal Infirmary of Edinburgh. Bovine samples obtained from bovine mastitis cases, and from an animal
(cow 2211) without a history of S. aureus infection, were provided by C. Smyth, originally obtained from the
Teagasc Dairy Production Centre in Moorepark, Fermoy, County Cork, Ireland.
cData reported previously (14).
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SED, SEE, SElX, and TSST-1, as a result of exposure during colonization or infection (14,
32, 33). The present study corroborates previous observations which showed that
despite the relatively high prevalence of the egc cluster in clinical isolates of S. aureus,
neutralizing antibodies are rare (34).
This suggests that either the egc SAgs are poorly expressed during infection or the
host is unable to generate antibodies due to low T or B cell reactivity. Importantly, in
this study, we have shown that SElY, SElZ, and, to a lesser extent, SElU and SEI are
expressed by S. aureus in vivo. Antibodies against SElY and SElZ have been detected in
at least one serum sample each of bovine and human origin, consistent with a role in
pathogenesis in both host species.
Although our data suggest low levels of expression of some SAgs, it is feasible that
they can contribute to S. aureus immune modulation. For example, we recently
demonstrated that suboptimal stimulation of human T cells with a low concentration
of SAg (1 ng/ml) induced CD8 CD25 FOXP3 regulatory T cells that strongly
suppress the activation of effector T cells (35). A similar phenomenon can be observed
in the bovine system, as immunosuppressive CD4 CD25 FOXP3 cells are activated
with equivocally low concentrations of SAg (1 ng/ml) (36).
RF122-encoded SAgs are mitogenic for bovine T cells. In order to examine the
mitogenicity of each of the 11 identified SAgs, we constructed a SAg-deficient mutant
of S. aureus strain RF122 to facilitate plasmid-mediated expression of each SAg in
isolation by its native S. aureus strain. S. aureus RF122-1, a TSST-1-deficient derivative of
RF122, was constructed previously by allele replacement of the tst gene with a
tetracycline resistance cassette (17). In turn, we sequentially deleted the sec, sel, egc,
selx, sely, and selz genes by allele replacement (see Fig. S1 in the supplemental
material), resulting in the sequential mutants RF122-2 to RF122-7 and the final SAg-
deficient derivative RF122-8 (Table S3 and Fig. S1). Finally, to limit Hla-mediated toxicity
for T cells, we constructed hla mutants in the parent strain RF122 and SAg-deficient
derivatives, resulting in strains RF122t- and RF122-8, respectively (Table S3). The
mutants were validated to rule out that spurious mutations accrued during in vitro
passage that impact secreted virulence proteins (Fig. S2). Analysis of the mitogenicity
of stationary-phase and mid-exponential-phase culture supernatants of RF122 and
RF122-8 confirmed the loss of all detectable mitogenic activity (Fig. S2).
The superantigenic activities of RF122-encoded SECbov, TSST-1bov and SElXbov were
described previously (14–17). In order to examine the mitogenic potential of all SAgs
encoded by RF122 expressed in a native S. aureus background, SAg genes were cloned
into the inducible expression plasmid pALC2073. This allowed controlled expression in
the SAg-deficient strain RF122-8, facilitating analysis of the effects of individual SAgs
produced in their native strain context on bovine T cells in vitro. Proteins of the
predicted molecular weights were detected in supernatants of induced RF122-8
cultures for each SAg plasmid construct, with the exceptions of SEGbov, SElNbov, SEIbov,
and SElObov. (Fig. S3). To examine the mitogenicity of RF122-encoded SAgs for bovine
T cells, culture supernatants of RF122-8 containing pALC2073::SAg constructs and
recombinant SAg proteins were used to stimulate bovine peripheral blood mononu-
clear cells (PBMCs), and proliferation was measured by using a thymidine incorporation
assay (Fig. 4). Mitogenic activity for bovine T cells was detected for 7 of the 11 SAgs
expressed in the SAg-free strain RF122-8, including TSST-1, SECbov, SELbov, SEIbov,
SElNbov, SElX, and SElZbov, at total protein concentrations ranging from 10 pg/l to 10
ng/ml, but there was no detectable mitogenic activity for SElObov, SEGbov, SElUbov, and
SElY (Fig. 4a). However, recombinant proteins rSEGbov, rSElUbov, and rSElY expressed in
Escherichia coli could stimulate T cell proliferation at higher concentrations (Fig. 4b).
Accordingly, of the 11 SAgs encoded by RF122, only SElObov did not exhibit any
capacity for stimulation of bovine T cells. Taken together, these data indicate that
RF122 encodes an array of SAgs that are potent bovine T cell mitogens.
RF122-encoded SAgs have the capacity to stimulate the entire bovine V
repertoire. Most previous studies of the bovine V-dependent T cell activation capac-
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ity of staphylococcal SAgs have been limited by the number of identified bovine V
subfamilies (15, 17). Recently, we developed a novel qRT-PCR assay that is representa-
tive of the full complement of bovine V subfamilies (14). Supernatants from
tetracycline-induced cultures of RF122-8 containing pALC2073::SAg constructs were
used to stimulate bovine T cells. If the supernatant was unable to induce proliferation
at a total protein concentration of 0.01 g/ml, purified recombinant protein was used
as an alternative to determine the bovV profile (Fig. 5). Accordingly, in the present
study, we were able to comprehensively evaluate the responses of 18 bovV subfam-
ilies to stimulation with all RF122-encoded SAgs by qRT-PCR (Table 3 and Fig. 5). In
order to examine the host specificity of bovine SAgs, we also examined the capacities
of the recently characterized SAgs SElY and SElZ to stimulate V-dependent activation
of human T cells (Fig. 6 and Table 3). We found that all SAgs encoded by RF122, with
the exception of SElObov, induced V-specific stimulation of bovine T cells (Fig. 5), with
a unique bovV activation profile similar to human V (humV) T cell activation profiles
(37). Of note, the data indicate that each of the 18 bovV subfamilies tested are
FIG 4 Proliferation of bovine T cell populations in response to stimulation with RF122-encoded SAgs. Shown are
data for PBMC proliferation after 4 days of exposure to RF122-8 supernatants containing SAgs (a) and recombinant
SAg proteins (b), as indicated by the incorporation of [3H]thymidine. Results shown are the means of data from at
least triplicate measurements from 2 animals  standard errors of the means (SEM).
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FIG 5 RF122-encoded SAgs are able to stimulate all V subsets of the bovine T cell population. (a to j) Relative fold changes in bovine V expression after
stimulation with RF122 SAgs. Bovine V subfamilies were named according to the classification described previously by Arden et al. (47). The bovine TRBV
(Continued on next page)
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activated by at least one RF122-encoded SAg, such that RF122 has the potential to
stimulate the entire bovV repertoire (Fig. 5). Remarkably, the 3 SAgs encoded by
SaPIbov alone activate 13 of 18 bovV subfamilies, highlighting the potential impor-
tance of SaPIbov in bovine immune evasion. In comparison, despite being twice in
number, the egc SAgs activate only 11 of 18 subfamilies. Extensive duplication within
the bovV repertoire has resulted in 9 multimember subgroups, the largest of which,
bovV1, -10, and -13, contain 23, 9, and 20 functional TRBV genes, respectively (18, 19).
Each of the SaPIbov-encoded SAgs, SECbov, SElLbov, and TSST-1bov and the egc-encoded
SAg SEIbov can activate at least one of these large subfamilies each (Fig. 5). SElLbov
activates both bovV1 and -10, which is consistent with the large proportion of T cells
that are induced in response to stimulation with this SAg (Fig. 4 and 5). It was shown
previously that all humV subfamilies (with the exception of humV4 and -11) are
activated by at least one SAg (2). Our data also indicate that some bovV subfamilies
can be activated by multiple SAgs, for example, V16 and -X are activated by 6
RF122-encoded SAgs, and V24 and -17 are activated by 5 of them. This apparent
functional redundancy implies that the activation of these V subfamilies is of critical
importance in S. aureus infection. A similar redundancy has been observed in the
humV response to SAgs, with V1, -3, -5, -6, -9, -12, -18, and -21 being targeted by at
least 5 or more different SAgs (2).
Evidence for host adaptation by bovine S. aureus SAgs. For the recently char-
acterized SAgs SElY and SElZ, we examined the V-dependent activation of human and
bovine T cells. We utilized protein variants for both SElY and SElZ derived from human
and bovine isolates to investigate the possibility of host adaptation. Both human and
bovine variants of SElY and SElZ induced similar levels of expansion of human T cells
(Fig. 6a). SElY induced the expansion of a broad number of human V subfamilies (Fig.
6b), while SElZ induced the expansion of a single human V subfamily (subfamily 13.2).
In contrast to the human V expansion profile, both human and bovine variants of SElY
and SElZ activated different bovV subfamilies. SElZbov activated bovV subfamilies 1,
3, 7, 11, 16, 17, 24, 28, and X, while human SElZ (SElZhum) activated bovV subfamilies
24, 28, and X (Fig. 6c). It is also noteworthy that SElZbov exhibited a 10-fold-higher
potency than SElZhum for stimulating bovine T cell proliferation (Fig. 6a). This could be
explained by the activation of a broader number of bovV subfamilies by SElZbov than
FIG 5 Legend (Continued)
genes analyzed are functional genes tested previously (14). Bovine T cells were stimulated with supernatants from induced RF122-8 cells containing
pALC2073::SAg constructs (a to f) or purified recombinant proteins (g to j). Results are given as mean fold changes in expression  SEM from 6
measurements, 3 each from two animals. * indicates expansion of a subfamily based on a significant increase from the baseline (P  0.05). (k) Expansion
profiles of all 11 SAgs from RF122.
TABLE 3 Activation of V subfamilies in response to RF122-encoded SAgs
SAg
Bovine V subfamily(ies)
activateda
Human V subfamily(ies)
activateda,b
SECbov 15, 17, 28 12, 13, 14, 15, 17, 20
SEIbov 1, 10, 16 1, 5, 6, 23
SElLbov 1, 5, 6, 7, 10, 16, 24 1, 5, 7, 16, 22, 23
SElNbov 3, 9, 16, 24, X 7, 8, 9, 17
SElXbov 3, 5, 8, 11, 16, 17, 24, X 1, 6, 18, 21
TSST-1bov 2, 4, 24, X 2
SEGbov 3, 5, 13, 15, 17, X 3, 12, 13, 14, 15
SElUbov 17 13, 14
SElYbov 4, 7, 10, 16, 24, 28, X 1, 2, 3, 5, 6, 7, 15, 21, 22,
23, 24
SElZbov 1, 3, 7, 11, 16, 17, 24, 28, X 13.2
SElObov NA 5, 7
aV subfamilies were named according to the classification described previously by Arden et al. (47). Bovine
and human V subfamilies activated in response to the same SAg are highlighted in boldface type. NA, not
applicable.
bHuman V activation data were compiled previously or in this study for SElY and SElZ (11, 12, 14, 15).
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by the human variant (Fig. 6c). Strikingly, SElYbov induced the expansion of a broad
array of bovV subfamilies, while SElYhum was unable to induce the activation of bovine
T cells (Fig. 6a and c). Combined, these results suggest adaptive evolution of SElY and
SElZ to the bovine host.
FIG 6 SAgs exhibit host-dependent functional activity. (a) PBMC proliferation after 4 days of exposure to bovine and human alleles of SElY and
SElZ as indicated by the incorporation of [3H]thymidine. Results shown are the means of data from at least triplicate measurements from 3 donors 
SEM. Differences between proliferation induced by human and bovine variants of these SAgs were assessed by using two-way analysis of variance
(ANOVA) with a Holm-Sidak multiple-comparison test, and asterisks denote curves that are significantly different (*, P  0.05; **, P  0.01). (b)
Expansion index of V human CD3 cells after stimulation with human and bovine alleles of SElY and SElZ. The expansion index was determined
from the means of three measurements from 2 donors  SEM. * indicates expansion of a subfamily based on a significant increase from the
baseline (P  0.05) and an expansion index of 1. (c) Relative fold changes in bovine V expression after stimulation with human and bovine
alleles of SElY and SElZ. Results are given as mean fold changes in expression SEM from 9 measurements, 3 each from three animals. * indicates
expansion of a subfamily based on a significant increase from the baseline (P  0.05).
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Analysis of the protein variants SElY and SElZ revealed a number of unique residues
that may be responsible for the difference in phenotypes observed between the human
and bovine variants (see Fig. S4 in the supplemental material). For SElY, three positions
varied between the bovine allele from RF122 (ST151) and the human allele from
MSA2020 (ST121) (E19G, T67A, and I183V). In particular, the glutamic acid residue at
position 19 was identified in the SElY allele of ST151 and other cattle isolates (ST3140,
-504, -706, and -3099) but not in any of the SElY variants of human origin. For SElZ, four
positions varied between the bovine allele from RF122 (ST151) and the human allele
from MSA1695 (P6L, N55S, D75N, and G106A). Of note, the glycine residue at position
106 of RF122 SElZ was found in all but one of the bovine SElZ variants analyzed and was
absent among the majority of human variants (6/8).
Some of the differences between human and bovine V activation profiles are due
to the absence of an orthologous subgroup, such as the activation of humV12, -14,
-20, -22, and -23 (absent in bovine) and bovV10, -28, and -X (absent in human) (18).
However, there are cases where V subfamilies from one host are activated but the
orthologous subgroup from the other is not (Table 3). For example, SElLbov activates
bovV6 and -24 but not humV6 and -24, TSST-1bov activates only bovine V4 and -24,
SEIbov activates bovV16 and humV5 and -6 but not the equivocal variants in the
opposite species, and SElNbov activates bovV3, -16, and -24 and humV7 and -8 but
not the equivalent human or bovine subgroups. It is important to note that with the
exception of SECbov and SElXbov, the human V profiles described here were deter-
mined in previous reports in response to stimulation with SAgs derived from human S.
aureus strains (11, 12). It is feasible that distinct human V profiles could be stimulated
by bovine SAg variants. Our analysis of SElY and SElZ and a previous analysis of SElX (14)
support the notion that allelic variants of SAgs made by S. aureus from different host
species have evolved to preferentially activate the V repertoire of the strains of the
target host. Together, these data indicate that some SAgs encoded by bovine S. aureus
have undergone host adaptation associated with broader stimulation of V subfamilies
and increased potency of bovine T cell activation. Furthermore, we report that SElY and
SElZ are classical SAgs in that they have unique V activation profiles with the capacity
to mediate immune modulation in both humans and cattle.
Preliminary examination of the role of SAgs in the pathogenesis of bovine
mastitis. The functional analysis of bovine SAgs made by a single strain in the present
study suggests a profound role in host-pathogen interactions and pathogenesis. In
order to examine the role of SAgs in S. aureus bovine mastitis, preliminary experimental
infections of bovine mammary glands were carried out using RF122 and RF122-8 over
a course of 21 days. Seven healthy dairy cows in their 1st to 4th lactation were enrolled
in two groups of 4 and 3 cows and challenged with wild-type (WT) RF122t and the
SAg-deficient strain RF122-8, respectively. There were no differences observed between
the groups in terms of somatic cell counts, milk yields, and core body temperatures (see
Fig. S5 in the supplemental material). S. aureus was isolated from the mammary glands
of all animals during the trial; taken together with the milk quality and somatic cell
counts, these data indicate that SAgs are not required to establish subclinical mastitis.
The group infected with wild-type RF122 exhibited clinical mastitis at least once, in
three out of the four animals infected during the course of the study (Fig. 7). In contrast,
clinical mastitis was not observed in the animals infected with the SAg-deficient
mutant. Although the study was not powered for statistical significance, the data are
suggestive of a role for bovine SAgs in the development of staphylococcal clinical
mastitis. Further experimentation would be required to confirm this preliminary obser-
vation.
We speculate that SAgs may contribute to pathogenesis through the expression of
some SAgs, such as SEC1 and TSST-1, at high concentrations to promote the release of
proinflammatory cytokines, which in turn induce tissue damage, inflammation, and
clinical pathology. Furthermore, some SAgs, such as egc-encoded SAgs, expressed at
low concentrations may induce immunosuppressive regulatory T cells to promote
colonization of the host.
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Concluding comments. In conclusion, the role of SAgs during pathogenesis is very
complex. The array of identifiable staphylococcal SAgs is expanding and has been
expedited with advances in genomic analyses. The extensive diversity is potentially
driven by the need to activate a large number of T cells and bind to major histocom-
patibility complex (MHC) class II molecules in multiple ways, contributing to immune
evasion. Our findings contribute to the understanding of staphylococcal SAg diversity
and provide a comprehensive analysis of the bovine T cell response to SAgs. In
addition, we report examples of toxins that contribute to the capacity of S. aureus to
adapt to different host species.
MATERIALS AND METHODS
Ethics statement. All in vivo work was done after local ethical review, under the oversight of the
Kalamazoo IACUC, and in accordance with local, state, and federal animal welfare regulations. Bovine
venous blood was taken under the authority of a UK Home Office project license (PPL 604394) within the
terms and conditions of the regulations of the UK Home Office Animals (Scientific Procedures) Act of
1986 and the code of practice for the housing and care of animals bred, supplied, or used for scientific
purposes. Human venous blood was taken from healthy donors in accordance with a human subject
protocol approved by the National Research Ethics Service (NRES) Committee of South East Scotland
under research ethics committee reference number 11/AL/0168. Volunteers were recruited by a passive
advertising campaign within The Roslin Institute (University of Edinburgh), and written consent was
given by each volunteer before each sample was taken.
Bacterial culture conditions. S. aureus strains were grown in tryptone soya broth (TSB) or brain heart
infusion (BHI) broth (Oxoid, UK) shaken at 200 rpm or on tryptone soya agar (TSA) (Oxoid, UK) at 37°C
for 16 h unless otherwise stated. E. coli strains were grown in Luria-Bertani (LB) broth (Melford
Laboratories, UK) shaken at 200 rpm or on LB agar (Melford Laboratories, UK) at 37°C for 16 h unless
otherwise stated. Media were supplemented where appropriate with 150 g/ml X-gal (5-bromo-4-
chloro-3-indolyl--D-galactopyranoside), 50 g/ml ampicillin, and 10 g/ml erythromycin or chloram-
phenicol (Sigma-Aldrich, Dorset, UK). For growth curve analysis of S. aureus, strains were cultured
overnight in 5 ml BHI broth (Oxoid Ltd., Basingstoke, UK) in triplicate. After 12 h, strains were subcultured
at a dilution of 1:100 into 30 ml fresh BHI broth in 250-ml Erlenmeyer flasks and placed in a shaking
incubator at 37°C at 200 rpm. Absorbance readings were measured at 600 nm (optical density at 600 nm
[OD600]) using a spectrophotometer (Cecil Aurius CE2021; Thistle Scientific Ltd., Glasgow, UK) over a
period of 12 h, and a growth curve was determined.
Sequence analysis of staphylococcal SAg genes. The sequences of characterized staphylococcal
SAg genes were obtained from the NCBI GenBank database (see Table S1 in the supplemental material).
SAg homologs were identified in publicly available whole-genome sequences of bovine and represen-
tative human S. aureus genomes using BLASTn with a minimum alignment of 90% nucleotide identity
averaged across the entire gene sequence using the Blastable script (https://github.com/bawee/
blastable). Representative genomes with unique sequence types and SAg contents were selected, and a
core genome alignment was built using Parsnp (38). The association between SAg content and
phylogeny was visualized using iTol (39). Nucleotide sequences corresponding to each reference SAg
were aligned at the codon level using translatorx and mafft (40, 41). A maximum likelihood tree was
constructed from the translated amino acid alignment using RAxML (v8.2.10) with the following settings:
—m PROTCATAUTO —f a —N 1000 —x 123 —p 123 (42). BRIG (43) was used to construct the circular
genome representation and GC content plot with the S. aureus RF122 genome sequence (GenBank
accession number AJ938182) as a reference.
Transcriptional analysis of SAg genes. Total RNA was extracted from S. aureus strain RF122
exponential-phase (OD600  0.6) and stationary-phase (12-h) cultures using the RNeasy miniprep kit
FIG 7 SAgs promote clinical bovine mastitis. Shown is the number of animals infected with RF122 or
RF122-8 that exhibited evidence of clinical mastitis at any point during the 21 days of the trail. Clinical
mastitis in this experiment was defined as observable inflammation in any of the four quarters of the
cow’s udder during the study.
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(Qiagen, UK) according to the manufacturer’s instructions except for an added lysis step with resuspen-
sion of the bacterial pellet in Tris-EDTA (TE) buffer with 100 g/ml lysostaphin and incubation at 37°C for
20 min. RNA was treated with Turbo DNase (Thermo Fisher, UK). A total of 0.5 g mRNA was analyzed
for gene transcription using the same protocol as the one outlined by Wilson et al. (14). SAg primers are
listed in Table S2 in the supplemental material.
Allelic replacement of SAg genes. Gene deletion constructs of SAg genes in RF122 were performed
by using constructs prepared in plasmid pMAD (44) (see Table S3 in the supplemental material). Plasmid
construction and allelic replacement were performed as described previously (14, 44). The resulting
mutant strain, which had lost the gene of interest (GOI), was analyzed by PCR for no amplification with
primers within the deleted region or with pMAD MCS primers (see Table S2 in the supplemental
material). The mutant strains were also sequenced by using primers upstream (E) and downstream (Z) of
the GOI to confirm the predicted deletion event. Sequencing reactions were carried out by Edinburgh
Genomics (King’s Buildings, University of Edinburgh, UK). To investigate the possibility that deletion of
the genes could have pleiotropic effects, the phenotypes of WT and mutant strains were compared. First,
a growth curve was determined for RF122, RF122t, and RF122-8, grown in a BHI liquid culture for 10 h
at 37°C, which revealed that growth rates and yields were similar for each strain (Fig. S2). In addition, the
hemolysis of rabbit erythrocytes incubated with culture supernatants of RF122 and SAg-deficient
derivative strains was investigated. In each case, the hemolytic titer of RF122 and SAg-deficient
derivatives was 1,022, indicating that the deletion of SAg genes had no effect on hemolytic activity and
that the agr locus was functional (Fig. S2). Deletion of the hla gene in RF122 resulted in a reduction in
the hemolytic titer, indicating that these strains are less toxic than the wild type. Analysis of the profiles
of secreted and cell wall-associated (CWA) proteins of WT and mutant strains revealed no unexpected
differences (Fig. S2).
Analysis of S. aureus secreted and CWA proteins. Secreted and CWA proteins were extracted from
S. aureus mid-exponential-phase (OD600  0.6) and stationary-phase (12-h) cultures grown in BHI
medium. Cells were centrifuged at 4,000  g, and supernatant fractions containing secreted proteins
were removed and concentrated with Amicon Ultra-15 centrifugal filter units with a 10-kDa molecular
weight cutoff (MWCO) according to the manufacturer’s instructions (Merck Millipore, UK). To extract CWA
proteins, pelleted cells were washed with 1 ml phosphate-buffered saline (PBS) (Oxoid, Cambridge, UK),
resuspended in 1 ml lysis buffer (50 mM Tris HCl, 20 mM MgCl2, and 30% raffinose [Fluka, UK], adjusted
to pH 7.5) containing 200 g/ml lysostaphin (AMBI Products LLC, NY, USA) and protease inhibitors
(Roche, UK), and incubated at 37°C for 20 min. Samples were centrifuged at 6,000  g for 20 min, and
CWA proteins were recovered from the supernatant fraction. Protein preparations were separated on
10% SDS-PAGE gels, stained overnight at room temperature with Coomassie blue (Severn Biotech), or
transferred to nitrocellulose membranes (Amersham Hybond ECL; GE Healthcare, Slough, UK) for Western
blot analysis. The membrane was incubated with primary antibody for 1 h with a 1:2,500 dilution of
anti-SEC (Santa Cruz Biotechnology, Heidelberg, Germany) or for 2 h with a 1:2,000 dilution of rat
antiserum specific for rTSST-1, rSElL, or rSElXbov. The membrane was incubated with secondary antibody
for 1 h at a dilution of 1:2,500 (rabbit anti-mouse IgG; Zymed, Invitrogen, UK) or 1:1,500 (goat polyclonal
antibody to rat IgG-horseradish peroxidase [HRP]; Abcam, Cambridge, UK) and visualized by enhanced
chemiluminescence (ECL).
Cloning of SAg genes into pALC2073. 5= oligonucleotides to amplify RF122-borne SAg genes for
cloning into the expression plasmid pALC2073 were designed to prime upstream of the predicted
ribosome binding site (RBS) with a KpnI site incorporated to facilitate cloning (see Table S2 in the
supplemental material). The 3= primer was designed to include the stop codon of the gene with a SacI
site incorporated (Table S2). PCRs were carried out with 10 ng RF122 genomic DNA (gDNA) and 100 nmol
forward and reverse primers, as listed in Table S2 in the supplemental material, using 1 U Vent
polymerase (New England BioLabs, Herts, UK) according to the manufacturer’s instructions. PCR products
were cloned into the Strataclone pSC-B plasmid (Agilent, Cheshire, UK), and inserts were released by
digestion with SacI and KpnI for 3 h at 37°C, purified by gel extraction, ligated with digested pALC2073
plasmid DNA using T4 DNA ligase, and transformed into E. coli DH5 cells. The resulting pALC2073::SAg
plasmids were isolated from DH5 cells and transformed by electroporation into an intermediate
electrocompetent strain of S. aureus, RN4220. Subsequently, the plasmids were reisolated and trans-
formed into the SAg-deficient strain RF122-8. S. aureus strains were made competent as described
previously (14). RF122-8 strains containing each of the pALC2073::SAg constructs were induced with a
subinhibitory concentration of tetracycline (50 ng/ml) (Sigma-Aldrich, Dorset, UK) when cultures reached
mid-exponential phase and grown for a further 4 h.
Recombinant expression of SAg genes. 5= primers for cloning into the pET15b (Merck Millipore, UK)
or pQE30-Xa (Qiagen, UK) plasmid were designed to anneal immediately after the signal peptide coding
region, as predicted by the Signal P 3.0 server (http://www.cbs.dtu.dk/services/SignalP/), and 3= primers
were designed to include the stop codon of the gene (see Table S2 in the supplemental material). The
cloning procedure was performed as outlined above for pALC2073, and ligated constructs were
transformed into E. coli DH5 or XL1-Blue (for pQE30-Xa constructs) cells. pET constructs were isolated
from DH5 cells using the QIAprep spin miniprep kit (Qiagen, UK) and transformed into E. coli BL21(DE3)
cells. BL21 or XL1-Blue cells containing expression constructs were cultured in Luria broth containing 50
g/ml ampicillin (Sigma-Aldrich, Dorset, UK) and induced in the mid-exponential phase of growth (OD600 
0.6) with 1 mM isopropyl--D-1-thiogalactopyranoside (IPTG) (ForMedium Ltd., Norfolk, UK) for 4 h. Cells
were recovered by centrifugation at 8,000  g and disrupted by using a French press, and His-tagged
recombinant proteins were purified by affinity chromatography on a Ni-nitrilotriacetic acid (NTA) nickel
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affinity column (GE Healthcare, UK). Proteins were dialyzed by using Spectra/Por Float-A-Lyzer tubing
with an 8,000 to 10,000 MWCO (Spectrum Laboratories, CA, USA).
Immunoblot analysis of convalescent-phase bovine serum. SDS-PAGE and Western blotting were
carried out on SAgs overexpressed in E. coli. The nitrocellulose membrane (Amersham Hybond ECL; GE
Healthcare, Slough, UK) was incubated with 10 ml of blocking buffer containing 5% (wt/vol) skimmed
milk powder (Sigma-Aldrich, UK) in PBST (PBS with 0.05% Tween 20 [Sigma-Aldrich, UK]) overnight at 4°C.
The membrane was then incubated for 2 h with a 1:1,000 dilution of pooled bovine convalescent-phase
serum in PBST with 1% (wt/vol) skimmed milk and washed three times with PBST. Secondary antibody
(goat anti-bovine IgG-HRP; Santa Cruz Biotechnology, Heidelberg, Germany) was added at a concentra-
tion of 400 ng/ml for 1 h at room temperature. The blot was washed again. Immunoreactivity was
visualized by chemiluminescence from ECL.
T cell proliferation assays. Blood was obtained from Holstein-Friesian cattle aged 18 to 36 months
via jugular vein puncture. Animals were reared indoors and maintained on a ration of hay and
concentrates. PBMCs were isolated by density gradient centrifugation using Ficoll Paque plus (GE
Healthcare, UK) as described previously (45). Human PBMCs were isolated from venous blood drawn from
healthy human volunteers and mixed with acid-citrate-dextran (ACD) (25 g D-glucose [Sigma-Aldrich, UK]
and 20.5 g trisodium citrate [Sigma-Aldrich, UK] added to 1 liter of double-distilled water [ddH2O]). The
buffy coat was isolated by spinning the blood at 1,500  g for 15 min with no break, and PBMCs were
then isolated by using Ficoll Paque plus (GE Healthcare, UK) according to the manufacturer’s specifica-
tions. PBMCs were adjusted to a concentration of 1 106 cells/ml in complete cell culture medium (RPMI
1640 [Sigma-Aldrich, UK] supplemented with 10% [vol/vol] heat-inactivated fetal calf serum [Gibco, UK]
and 100 U/ml penicillin, 100 g/ml streptomycin, and 292 g/ml L-glutamine. [PSG] [Gibco, UK]) and
stimulated at least in triplicate with the concentrated total protein S. aureus supernatant fraction or
recombinant protein. Culture medium and 50 g/ml concanavalin A were used as negative and positive
controls, respectively. Proliferations of bovine and human PBMCs were assessed by a [3H]thymidine
incorporation assay as described previously (14). Total RNA was extracted from bovine PBMCs (4  106
cells) by using Tri reagent (Sigma-Aldrich, Dorset, UK) according to the supplier’s instructions or by using
the RNeasy plus kit (Qiagen, UK) according to the manufacturer’s instructions. First-strand cDNA was
generated from 0.5 g of RNA using a Power SYBR green RNA-to-CT 2-step kit or a high-capacity
RNA-to-cDNA kit and Power SYBR green PCR master mix (Thermo Fisher, UK). The reverse transcription
reaction was performed with a 20-l volume according to the manufacturer’s specifications. Bovine V
subfamily-specific qRT-PCRs were carried out as described previously (14). Human V activation analysis
was performed as described previously (12, 46).
Experimental infection of dairy cattle. Adult cows (Holstein) in their 1st to 4th lactation at 92 to
174 days in milk (DIM) were used in this study. Cultures of S. aureus grown overnight were inoculated
1:50 into fresh TSB and grown until an OD600 of 1.1 was reached. Staphylococci were diluted in TSB to
obtain an inoculum of 5  107 CFU/ml. Inocula were determined by CFU enumeration following serial
dilution, plating on TSA, and growth at 37°C. Animals were challenged via teat dip immersion twice daily
(22-mm immersion) until a score of 1 or higher for milk appearance or udder evaluation was observed
and the animal developed an intramammary infection twice within a 5-day period. Following infection,
animals were observed for a total of 3 weeks. Somatic cell counts (SCCs) and cultures were performed
twice a week. Udder and milk clinical scores and milk yield and milk conductivity data were collected at
each milking, which was performed twice daily.
Statistical analysis. All statistical analysis was performed in GraphPad Prism 7. Fold change enrich-
ment data were analyzed by using the Student t test with Welch’s correction if required. Tests were
unpaired and two tailed, and significant differences were considered when the P value was 0.05.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/IAI
.00505-18.
SUPPLEMENTAL FILE 1, PDF file, 1.0 MB.
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